Publicacións en colaboración con investigadores/as de University of Tasmania (3)

2017

  1. Five-year Efficacy and safety of tocilizumab monotherapy in patients with rheumatoid arthritis who were methotrexate-And biologic-naive or free of methotrexate for 6 months: The ambition study

    Journal of Rheumatology, Vol. 44, Núm. 2, pp. 142-146

2013

  1. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492

2010

  1. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 1, pp. 88-96